| review article | Q7318358 |
| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | G. Justus Hofmeyr | Q56273613 |
| A Metin Gülmezoglu | Q89879097 | ||
| P2093 | author name string | G J Hofmeyr | |
| P2860 | cites work | Misoprostol versus low-dose oxytocin for cervical ripening: a prospective, randomized, double-masked trial | Q30309857 |
| Labor induction with misoprostol | Q33716300 | ||
| Maternal mortality following the use of misoprostol | Q33847269 | ||
| Misoprostol induction of labor among women with a history of cesarean delivery | Q34249043 | ||
| Misoprostol and illegal abortion in Rio de Janeiro, Brazil | Q34334923 | ||
| In vitro characterization of prostanoid receptors on human myometrium at term pregnancy | Q35871450 | ||
| Misoprostol for cervical ripening and labor induction: a meta-analysis. | Q38558855 | ||
| Vaginal misoprostol as an alternative to oxytocin for induction of labor in women with late fetal death | Q38925228 | ||
| Uterine and fetal Doppler flow changes after misoprostol and oxytocin therapy for induction of labor in post-term pregnancies | Q39528102 | ||
| Misoprostol and dinoprostone therapy for labor induction: a Doppler comparison of uterine and fetal hemodynamic effects. | Q39637505 | ||
| Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk? | Q41672392 | ||
| Uterine rupture during induction of labor at term with intravaginal misoprostol | Q42056486 | ||
| Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction. | Q42165727 | ||
| Extemporaneous preparation of misoprostol gel for cervical ripening: a randomized trial. | Q42546135 | ||
| Vaginal misoprostol for induction of labor: 25 vs. 50 microg dose regimen | Q43516615 | ||
| Misoprostol versus dinoprostone for cervical priming prior to induction of labour in term pregnancy: a randomised controlled trial | Q43673819 | ||
| Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone | Q43697274 | ||
| Randomized controlled trial of 50 and 100 mcg of misoprostol for induction of labor at term | Q43740827 | ||
| Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus | Q43771701 | ||
| Comparison of 25 and 50 microg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. | Q43861665 | ||
| Oral and vaginal misoprostol compared with dinoprostone for induction of labor: a randomized controlled trial | Q43868674 | ||
| Prostaglandin E2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks | Q43868676 | ||
| Uterine rupture associated with use of misoprostol for induction of labor | Q43871059 | ||
| Labor induction with vaginal misoprostol and extra-amniotic prostaglandin F2alpha gel. | Q43871063 | ||
| Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostone. | Q43885335 | ||
| Randomized study of vaginal misoprostol (PGE(1)) and dinoprostone gel (PGE(2)) for induction of labor at term | Q43885873 | ||
| Induction of labor in toxemia with misoprostol | Q43967089 | ||
| The effect of tablet moistening on labor induction with intravaginal misoprostol: a randomized trial | Q44019725 | ||
| A still birth and uterine rupture during induction of labour with oral misoprostol | Q44196426 | ||
| Labor induction and meconium: in vitro effects of oxytocin, dinoprostone and misoprostol on rat ileum relative to myometrium | Q44223105 | ||
| Intracervical misoprostol and prostaglandin E2 for labor induction | Q44278045 | ||
| No benefit, but increased harm from high dose (100 microg) misoprostol for induction of labour: a randomised trial of high vs. low (50 microg) dose misoprostol | Q44294384 | ||
| Comparative efficacy and cost of the prostaglandin analogs dinoprostone and misoprostol as labor preinduction agents | Q44319706 | ||
| Dinoprostone versus misoprostol: a randomized study of nulliparous women undergoing induction of labor | Q44369454 | ||
| Randomized trial in multiparous patients: investigating a single vs. two-dose regimen of intravaginal misoprostol for induction of labor | Q44369457 | ||
| Labor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol | Q44454511 | ||
| Misoprostol versus oxytocin for labor induction in term and post-term pregnancy: randomized controlled trial | Q44550858 | ||
| Induction of labor with intravaginal misoprostol versus intracervical dinoprostone | Q45109433 | ||
| A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction | Q46068377 | ||
| A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction | Q46194741 | ||
| Oral or vaginal misoprostol for induction of labor | Q46321147 | ||
| A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction | Q46402297 | ||
| Misoprostol: an effective agent for cervical ripening and labor induction | Q46660314 | ||
| Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery | Q46731524 | ||
| Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. | Q52925785 | ||
| Uterine rupture during induced trial of labor among women with previous cesarean delivery | Q61836441 | ||
| Uterine rupture associated with vaginal birth after cesarean section: a complication of intravaginal misoprostol? | Q61836456 | ||
| Misoprostol to induce labour | Q67512970 | ||
| Uterine hyperstimulation after low-dose prostaglandin E2 therapy: tocolytic treatment in 181 cases | Q68157314 | ||
| Misoprostol and congenital malformations | Q68305168 | ||
| Cervical priming with oral misoprostol in pre-labor rupture of membranes at term | Q71123951 | ||
| Preinduction cervical ripening with intravaginal prostaglandin E1 methyl analogue misoprostol: a randomized controlled trial | Q71232636 | ||
| Labor induction with intravaginal misoprostol versus intracervical prostaglandin E2 gel (Prepidil gel): randomized comparison | Q71552505 | ||
| Vaginal misoprostol for induction of labor: a randomized controlled trial | Q71614624 | ||
| Comparison of labor induction with misoprostol vs. oxytocin/prostaglandin E2 in term pregnancy | Q71876626 | ||
| Intravaginal misoprostol as a cervical ripening agent | Q72919110 | ||
| Randomized comparison between intravaginal misoprostol and dinoprostone for cervical ripening and induction of labor | Q72989777 | ||
| Outpatient cervical ripening with intravaginal misoprostol | Q73103623 | ||
| A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacy | Q73114822 | ||
| Oral administration of misoprostol for labor induction: a randomized controlled trial | Q73114826 | ||
| A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices | Q73183088 | ||
| Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study | Q73384837 | ||
| A comparative trial of labor induction with misoprostol versus oxytocin | Q73419288 | ||
| Absorption kinetics of misoprostol with oral or vaginal administration | Q73477328 | ||
| Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes | Q73478625 | ||
| Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction | Q73682130 | ||
| Randomised trial of one versus two doses of prostaglandin E2 for induction of labour: 1. Clinical outcome | Q73723550 | ||
| A comparison of intravaginal misoprostol and intracervical prostaglandin E2 gel for ripening of unfavorable cervix and labor induction | Q73733490 | ||
| Cervical ripening in the third trimester of pregnancy with intravaginal misoprostol: a double-blind, randomized, placebo-controlled study | Q73780252 | ||
| A double-blind comparison of the safety and efficacy of intravaginal misoprostol and prostaglandin E2 to induce labor | Q73937672 | ||
| A randomized clinical trial comparing misoprostol with prostaglandin E2 gel for preinduction cervical ripening | Q73937685 | ||
| Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial | Q74277346 | ||
| Misoprostol as a labor induction agent | Q74314825 | ||
| Cervical ripening: a randomized comparison between intravaginal misoprostol and an intracervical balloon catheter combined with intravaginal dinoprostone | Q74774120 | ||
| Comparison of the safety and efficacy of intravaginal misoprostol (prostaglandin E1) with those of dinoprostone (prostaglandin E2) for cervical ripening and induction of labor in a community hospital | Q77880768 | ||
| Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel | Q78147504 | ||
| P433 | issue | 1 | |
| 3 | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | misoprostol | Q416025 |
| P304 | page(s) | CD000941 | |
| P577 | publication date | 2001-01-01 | |
| 2003-01-01 | |||
| 2003-01-20 | |||
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Vaginal misoprostol for cervical ripening and induction of labour |
| Q46237141 | A randomized controlled trial comparing low dose vaginal misoprostol and dinoprostone gel for labor induction |
| Q54314698 | A randomized trial of oral misoprostol in premenopausal women before hysteroscopy. |
| Q35165734 | A randomized trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women |
| Q24200418 | Acupuncture for induction of labour |
| Q24247475 | Acupuncture for induction of labour |
| Q24201011 | Amnioinfusion for meconium-stained liquor in labour |
| Q24240642 | Amnioinfusion for meconium-stained liquor in labour |
| Q34062478 | Amniotomy alone for induction of labour |
| Q58792147 | Anaphylactic shock to vaginal misoprostol: a rare adverse reaction to a frequently used drug |
| Q24246329 | Breast stimulation for cervical ripening and induction of labour |
| Q42840538 | Clarifying the role of misoprostol in obstetrics |
| Q46236382 | Comparative evaluation of 25 μg and 50 μg of intravaginal misoprostol for induction of labor |
| Q37233898 | Comparative study of efficacy and safety of oral versus vaginal misoprostol for induction or labour |
| Q50890411 | Comparison between vaginal and sublingual misoprostol 50 µg for cervical ripening prior to induction of labor: randomized clinical trial. |
| Q24805731 | Comparison of misoprostol and dinoprostone for elective induction of labour in nulliparous women at full term: a randomized prospective study |
| Q37611217 | Comparison of two dosing regimens of vaginal misoprostol for labour induction: a randomised controlled trial |
| Q37407093 | Comparison of vaginal misoprostol with foley catheter for cervical ripening and induction of labor |
| Q44211102 | Concurrent use of Foley catheter and misoprostol for induction of labor: a randomized clinical trial of efficacy and safety |
| Q24236606 | Different methods for the induction of labour in outpatient settings |
| Q34282067 | Extra-amniotic prostaglandin for induction of labour. |
| Q24247703 | Homoeopathy for induction of labour |
| Q24246278 | Hyaluronidase for cervical ripening and induction of labour |
| Q21261343 | IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability |
| Q41495684 | Induction of labour at term with misoprostol: the experience of a Tunisian maternity ward |
| Q24243863 | Induction of labour for improving birth outcomes for women at or beyond term |
| Q35217881 | Induction of labour with a favourable cervix and/or pre-labour rupture of membranes |
| Q39465675 | Induction to delivery interval using transcervical Foley catheter plus oxytocin and vaginal misoprostol: A comparative study at Aminu Kano Teaching Hospital, Kano, Nigeria |
| Q24242743 | Intracervical prostaglandins for induction of labour |
| Q24240637 | Intravenous oxytocin alone for cervical ripening and induction of labour |
| Q24201211 | Mechanical methods for induction of labour |
| Q24245409 | Medical treatment for early fetal death (less than 24 weeks) |
| Q38990536 | Medical treatments for incomplete miscarriage |
| Q24240387 | Medical treatments for incomplete miscarriage (less than 24 weeks) |
| Q24242833 | Medical treatments for incomplete miscarriage (less than 24 weeks) |
| Q24240838 | Methods for cervical ripening and labour induction in late pregnancy: generic protocol |
| Q24240181 | Mifepristone for induction of labour |
| Q43056374 | Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial |
| Q24235913 | Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death |
| Q36981860 | Misoprostol for intrauterine fetal death |
| Q24801601 | Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357] |
| Q84590588 | Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects |
| Q35074421 | Misoprostol-is more research needed? |
| Q24200791 | Morning versus evening induction of labour for improving outcomes |
| Q24240498 | Morning versus evening induction of labour for improving outcomes |
| Q24236258 | Nitric oxide donors for cervical ripening and induction of labour |
| Q24243508 | Nitric oxide donors for cervical ripening and induction of labour |
| Q39029446 | Nitric oxide donors for cervical ripening and induction of labour. |
| Q37569806 | Obstetric outcome and significance of labour induction in a health resource poor setting. |
| Q34424941 | Oestrogens alone or with amniotomy for cervical ripening or induction of labour. |
| Q24194006 | Oral misoprostol for induction of labour |
| Q24246291 | Oral misoprostol for induction of labour |
| Q34421855 | Oral misoprostol for induction of labour at term: randomised controlled trial |
| Q33693531 | Outcome of misoprostol and oxytocin in induction of labour |
| Q37718892 | Predicting factors for success of vaginal delivery in preterm induction with prostaglandin E2 |
| Q24202508 | Prostaglandins before caesarean section for preventing neonatal respiratory distress |
| Q46472930 | Rectal misoprostol versus oxytocin in the management of the third stage of labour. |
| Q33441803 | Reducing stillbirths: interventions during labour |
| Q47813089 | Risk of caesarean delivery after induction of labour stratified by foetal sex. |
| Q37611084 | Shortening the induction delivery interval with prostaglandins: a randomized controlled trial of solo or in combination |
| Q37108198 | The impact of isosorbide mononitrate on cervical ripening and labor induction in primiparous women with term pregnancy: A double-blind, randomized, controlled trial |
| Q56919955 | The retained placenta |
| Q34612755 | Uses of misoprostol in obstetrics and gynecology |
| Q24234483 | Vaginal misoprostol for cervical ripening and induction of labour |
Search more.